MGTX (MeiraGTx Holdings) FFO


MGTX MeiraGTx Holdings PLC MGTX
51 GF Score
Price $12.02
GF Value $23.78
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is MeiraGTx Holdings FFO?

FFO (Funds from operations) only applies to REITs.

MGTX
51GF Score
MeiraGTx Holdings PLC MGTX
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is MeiraGTx Holdings (MGTX) Overvalued in 2026?

Based on GuruFocus' analysis, MeiraGTx Holdings stock appears to be undervalued. The current stock price of $12.02 is trading 49.5% below its estimated GF Value™ of $23.78. GuruFocus considers MeiraGTx Holdings to be Possible Value Trap.

Key valuation signals for MGTX:

  • FFO:
  • GF Value™: $23.78 vs. price of $12.02 (49.5% below fair value)
  • GF Score™: 51/100 with 5 warning signs

No single metric tells the full story. See the MGTX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

MeiraGTx Holdings Business Description

Other Exchanges 328:Germany
Address 655 Third Avenue, Suite 1115, New York, NY, USA, 10017
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.
51GF Score

Get the complete analysis for MGTX

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.02
Price
$23.78
GF Value